Aesthetic Medical International to Announce Unaudited Financial Results for the First Half of 2022 on August 17, 2022
- SHENZHEN, China, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it will release its unaudited financial results for the first half of 2022 before the U.S. market opens on Wednesday, August 17, 2022.
- 08/10/2022
|
Aesthetic Medical International Holdings Group Limited (AIH) CEO Dr. Pengwu Zhou on Q2 2021 Results - Earnings Call Transcript
- Aesthetic Medical International Holdings Group Limited (AIH) CEO Dr. Pengwu Zhou on Q2 2021 Results - Earnings Call Transcript
- 11/16/2021
|
Aesthetic Medical International to Announce Unaudited Financial Results for the Second Quarter and First Half of 2021 on November 16, 2021
- SHENZHEN, China, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it will release its unaudited financial results for the second quarter and first half of 2021 before the U.S. market opens on Tuesday, November 16, 2021.
- 11/08/2021
|
Aesthetic Medical International Announces Restructuring Plans to Optimize Business Operations
- SHENZHEN, China, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced a preliminary plan for business strategies and restructuring. In light of the time and efforts needed to assess the impact of such plan on its financial results, the Company currently anticipates that the release of its unaudited financial results for the three months and six months ended June 30, 2021 will be delayed.
- 09/30/2021
|
Aesthetic Medical International Holdings Group Limited (AIH) CEO Pengwu Zhou on Q1 2021 Results - Earnings Call Transcript
- Aesthetic Medical International Holdings Group Limited (AIH) CEO Pengwu Zhou on Q1 2021 Results - Earnings Call Transcript
- 06/24/2021
|
Aesthetic Medical International Holdings Group Limited Reports First Quarter 2021 Unaudited Financial Results
- SHENZHEN, China, June 24, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announced its unaudited financial results for the first quarter ended March 31, 2021.
- 06/24/2021
|
Aesthetic Medical International to Announce First Quarter 2021 Unaudited Financial Results on June 24, 2021
- SHENZHEN, China, June 16, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it will release its unaudited first quarter 2021 financial results before the U.S. market opens on Thursday, June 24, 2021.
- 06/16/2021
|
Aesthetic Medical International (AIH) Stock: Over 6% Increase Pre-Market Explanation
- The stock price of Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH) increased by over 6% pre-market. This is why it happened.
- 05/18/2021
|
Aesthetic Medical International Holdings Group Limited Announces USD$15.1 Million Private Placement with Lafang China Co., Ltd
- SHENZHEN, China, May 17, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announced that it has entered into a definitive share subscription agreement with Lafang China Co., Ltd (“Lafang”) to raise US$15.1 million through a private placement sale of 5,329,410 ordinary shares of the Company to Lafang at a sale price of US$8.50 every three ordinary shares (equivalent to US$8.50 per American Depositary Share of the Company). The private placement is subject to customary closing conditions and is expected to close within four months from the execution of the agreement. The Company intends to utilize the proceeds from this private placement to fund its business development and working capital.
- 05/17/2021
|
Aesthetic Medical International Holdings Group Limited Filed Annual Report on Form 20-F for 2020
- Shenzhen, China, April 30, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announced that it had filed its annual report on Form 20-F (the “Annual Report”) for the fiscal year ended December 31, 2020 with the U.S. Securities and Exchange Commission (the “SEC”) on April 30, 2021/ The annual report on Form 20-F, which contains the Company's audited financial statements, can be accessed on the SEC's website at http://www.sec.gov as well as via the Company's investor relations website at https://ir.aihgroup.net/. Hard copies of the annual report are available, free of charge, to shareholders upon request.
- 04/30/2021
|
Aesthetic Medical International's (AIH) CEO Pengwu Zhou on Q4 2020 Results - Earnings Call Transcript
- Aesthetic Medical International's (AIH) CEO Pengwu Zhou on Q4 2020 Results - Earnings Call Transcript
- 04/20/2021
|
Aesthetic Medical International Holdings Group Limited Reports Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results
- Shenzhen, China, April 20, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announces its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2020.
- 04/20/2021
|
Aesthetic Medical International Holdings Group Limited Announces Changes in its Committee Composition
- Shenzhen, China, March 30, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that Mr. Tsang Eric Chi Wai has resigned from the audit committee (the “Audit Committee”), the compensation committee (the “Compensation Committee”) and the nominating committee (the “Nominating Committee”) of the Company's board of directors (the “Board”) while remaining as a director on the Board; Mr. Xue Hongwei has resigned as the chair of the Nominating Committee while remaining as a member of the Nominating Committee; and Mr. Lu Feng has resigned as the chair of the Compensation Committee while remaining as a member of the Compensation Committee and as a member of the Nominating Committee. Their resignations from these committees did not result from any disagreement with the Company.
- 03/30/2021
|
Aesthetic Medical International Holdings Group Limited to Host Fourth Quarter and Fiscal Year 2020 Earnings Conference Call at 8:00 am ET on April 20, 2021
- Shenzhen, China, March 29, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announces that the Company will host its earnings conference call on Tuesday, April 20, 2021 at 8:00 am Eastern Time (5:00 am Pacific Time/ 8:00 pm Beijing Time) to discuss the Company's financial results of the fourth quarter and fiscal year ended December 31, 2020.
- 03/29/2021
|
Aesthetic Medical International Holdings Group Limited Announces Termination of Agreement to Acquire Controlling Interest in Guangdong Hanfei Investment Management Co., Ltd.
- Shenzhen, China, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that the Company has terminated the agreement to acquire a 51% equity interest in Guangdong Hanfei Investment Management Co., Ltd. (“Hanfei”), previously announced on July 14, 2020. The termination was a result of amicable negotiation of the parties following Hanfei's failure to meet the agreed-upon performance target largely due to the impact from the COVID-19 pandemic.
- 01/04/2021
|
Aesthetic Medical International's (AIH) CEO Pengwu Zhou on Q3 2020 Results - Earnings Call Transcript
- Aesthetic Medical International's (AIH) CEO Pengwu Zhou on Q3 2020 Results - Earnings Call Transcript
- 11/30/2020
|
Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) Short Interest Up 28.3% in September
- Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) was the target of a large growth in short interest during the month of September. As of September 30th, there was short interest totalling 57,100 shares, a growth of 28.3% from the September 15th total of 44,500 shares. Currently, 0.3% of the shares of the stock are short […]
- 10/18/2020
|
Financial Contrast: Aesthetic Medical International Holdings Group (NASDAQ:AIH) versus BioTelemetry (NASDAQ:BEAT)
- Aesthetic Medical International Holdings Group (NASDAQ:AIH) and BioTelemetry (NASDAQ:BEAT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation and risk. Valuation and Earnings This table compares Aesthetic Medical International Holdings Group and BioTelemetry’s […]
- 09/28/2020
|
Aesthetic Medical International Holdings Group Limited to Acquire Controlling Interest in Guangdong Hanfei Investment Management Co., Ltd., Marking the 4th Acquisitions in 2020
- Shenzhen, China, July 14, 2020 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announced the Company, through its affiliates, entered into a definitive agreement (the “Agreement”) to acquire Guangdong Hanfei Investment Management Co., Ltd. (“Hanfei”), marking the 4th acquisitions in 2020. Pursuant to the Agreements, the Company plans to acquire 51% equity interest in Hanfei, which owns and operates four aesthetic medical treatment centers in China.Founded in 2017 with headquarters in Guangzhou, China, Hanfei is a comprehensive aesthetic medical group providing surgical aesthetic service, non-surgical aesthetic service and other associated services. The acquisition of Hanfei is in line with the Company’s growth strategy in identifying, acquiring, and integrating treatment centers and will further enable the Company to respond to growing demand for aesthetic medical services nationwide. Hanfei will deploy the Company’s proven scalable business model with highly standardized operating procedures across a centralized network.Dr. Zhou Pengwu, the Chairman and CEO of the Company, commented, “We are thrilled to welcome Hanfei into the family of Aesthetic Medical International Holdings Group Limited, marking our 4th acquisition transaction in 2020. This transaction will enhance our capabilities and expand our customer base, while also providing us with a partner that shares in our commitment to customers and can add strategic and operational value. Based on our solid reputation and extensive experience in aesthetic medical industry, we are confident that our acquisition will enable us to execute on our strategy and next phase of growth.” About Aesthetic Medical International Holdings Group LimitedAIH, known as “Peng’ai” in China, is a leading provider of aesthetic medical services in China. AIH operates through treatment centers that spread across major cities in mainland China, and also has presence in Hong Kong and Singapore. Leveraging over 20 years of clinical experience, AIH provides one-stop aesthetic service offerings, including surgical aesthetic treatments, non-surgical aesthetic treatments, and general medical services and other aesthetic services. According to certain third party industry consultant, AIH was the third-largest private aesthetic medical services provider in China in terms of revenue in 2018. For more information regarding the Company, please visit: http://ir.aihgroup.net/. Safe Harbor StatementThis press release contains “forward-looking statements.” These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to” and similar statements. Statements that are not historical facts, including statements about the Company’s beliefs, plans and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. These risks and uncertainties and others that relate to the Company’s business and financial condition are detailed from time to time in the Company’s SEC filings, and could cause the actual results to differ materially from those contained in any forward-looking statement. These forward-looking statements are made only as of the date indicated, and the Company undertakes no obligation to update or revise the information contained in any forward-looking statements, except as required under applicable law.Investor Relations ContactFor investor and media inquiries, please contact:Aesthetic Medical International Holdings Group LimitedEmail: ir@pengai.com.cnAscent Investor Relations LLCMs. Tina XiaoTel: (917) 609-0333Email: tina.xiao@ascent-ir.com
- 07/14/2020
|
Aesthetic Medical International Holdings Group Limited to Acquire Controlling Interest in Jiangsu Liangyan Hospital Management Co., Ltd., Marking the 3rd Acquisitions in 2020
- Shenzhen, China, June 30, 2020 -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in.
- 06/30/2020
|
Aesthetic Medical International Holdings Group Limited Reports First Quarter 2020 Unaudited Financial Results
- Shenzhen, China, June 26, 2020 -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in.
- 06/26/2020
|
Aesthetic Medical International Holdings Group Limited to Host First Quarter 2020 Earnings Conference Call at 8:00 am ET on June 26, 2020
- Shenzhen, China, June 19, 2020 -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in.
- 06/19/2020
|
Aesthetic Medical International Holdings Group Limited Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2019
- Shenzhen, China, April 30, 2020 -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in.
- 04/30/2020
|
Aesthetic Medical International Holdings Group Limited Reports Fourth Quarter and Fiscal Year 2019 Unaudited Financial Results
- Shenzhen, China, April 24, 2020 -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in.
- 04/24/2020
|
Earnings Heat Up And Gold On Display
- Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
- 04/18/2020
|
Aesthetic Medical International Holdings Group Limited to Host Fourth Quarter and Fiscal Year 2019 Earnings Conference Call at 8:00 am ET on April 24, 2020
- Shenzhen, April 17, 2020 -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China,.
- 04/17/2020
|
Aesthetic Medical International Holdings Group Limited Enters into Definitive Agreements to Acquire Controlling Interest in Two Treatment Centers
- Shenzhen, April 02, 2020 -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China,.
- 04/02/2020
|
Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations now available for On-Demand Viewing
- Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations now available for On-Demand Viewing
- 03/26/2020
|
Aesthetic Medical International Holdings Group Limited Monitors and Responds to the Outbreak of COVID-19
- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, continuously monitors, and seeks to appropriately respond to, the evolving pandemic of the Novel Coronavirus Disease 2019 (“COVID-19”). The Company’s top priority is to ensure the health and safety of its customers, employees and their families. In response to the outbreak of COVID-19[1] in China, the Company postponed the resumption of operations of its aesthetic treatment centers in China after the Chinese New Year holiday in 2020.
- 03/17/2020
|
Aesthetic Medical International Holdings Group Limited to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on 18 March 2020
- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) based in Shenzhen, and focused on Aesthetic Medical Services, today announced that Chief Strategy Officer, Mr. Andrew Fan, will present at the dbVIC - Deutsche Bank American Depositary Receipt (ADR) Virtual Investor Conference on March 18. This virtual investor conference is aimed exclusively at introducing global companies with ADR programs to investors.
- 03/16/2020
|
Aesthetic Medical International Holdings Group Limited to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on March 18, 2020
- Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual event Shenzhen, March 12, 2020 -- Aesthetic Medical.
- 03/12/2020
|
International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on March 18th and 19th, 2020
|
Aesthetic Medical International Holdings Group Limited Announces Changes to Board of Directors
- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announced appointment of Ms. Cathy Peng as a member of the Board of Directors of the Company effective March 6, 2020 to replace Mr. Zhang Jianbin who step down due to personal reasons. Mr. Zhang Jianbin served as a director of the Company from March 2012 to February 2020, during which the Company completed its initial public offering and listing on the Nasdaq Global Market.
- 03/06/2020
|
Aesthetic Medical International Holdings Group Limited Launches Charity Campaign to Help Combat COVID-19
- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announced that the Company has launched a charity campaign to help combat coronavirus disease (COVID-19). The Company, through its 23 treatment centers across 17 cities in China, has intensified its efforts to help people in need. The Company organized charity fund raising activities among its employees and their family members, donated protective masks, thermometers and other medical supplies to the community, and allocated medical supplies for patients and healthcare personnel battling at the frontline.
- 02/18/2020
|
Aesthetic Medical International Holdings Group Limited Launches New Skincare Set
- Shenzhen, Jan. 13, 2020 -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China,.
- 01/13/2020
|
Aesthetic Medical International Holdings Group Limited Announces Openings of Two New Satellite Clinics
- Shenzhen, Dec. 30, 2019 -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China,.
- 12/30/2019
|
Aesthetic Medical International Holdings Group Limited Reports Third Quarter 2019 Unaudited Financial Results
- Shenzhen, China, Nov. 26, 2019 -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company”), a leading provider of aesthetic medical services in.
- 11/26/2019
|
Aesthetic Medical International Holdings Group Limited Announces Sales Results during VIP Sale Event and November 11 Sale Event
- Shenzhen, Nov. 22, 2019 -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company”), a leading provider of aesthetic medical services in China,.
- 11/22/2019
|
Aesthetic Medical International Holdings Group Limited to Host Third Quarter 2019 Earnings Conference Call at 8:00 am ET on November 26, 2019
- Shenzhen, Nov. 21, 2019 -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China,.
- 11/21/2019
|
Aesthetic Medical International Holdings Group Limited Redeems An Outstanding Convertible Note
- Aesthetic Medical International Holdings Group Limited (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that the Company has redeemed an outstanding convertible note on November 14, 2019. Immediately prior to the completion of the Company’s initial public offering of 7,500,000 ordinary shares of the Company, par value US$0.001 per share (“Ordinary Shares”), in the form of American depositary shares, the three outstanding exchangeable notes were exchanged into preferred shares of the Company, par value US$0.001 per share (“Preferred Shares”), and all the then outstanding Preferred Shares are all automatically converted into Ordinary Shares on a one-to-one basis.
- 11/20/2019
|
AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING
- Shenzhen, China, Oct. 30, 2019 -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in.
- 10/30/2019
|
AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING
- Aesthetic Medical International Holdings Group Limited (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced the pricing of its initial public offering of 2,500,000 American Depositary Shares (the “ADSs”), each representing three ordinary shares of the Company, at US$12.00 per ADS for the total offering size of approximately US$30.0 million, assuming the underwriters do not exercise their over-allotment option to purchase additional ADSs. The ADSs will begin trading on October 25, 2019, U.S. Eastern time, on the Nasdaq Global Market under the symbol “AIH.” The offering is expected to close on October 29, 2019, subject to customary closing conditions.
- 10/25/2019
|
